Donald Hooker
Stock Analyst at Keybanc
(1.70)
# 2,116
Out of 4,479 analysts
58
Total ratings
58.43%
Success rate
11.32%
Average return
Main Sectors:
18 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Overweight | $180 → $100 | $9.32 | +972.96% | 12 | Feb 23, 2022 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $450 → $390 | $203.24 | +91.89% | 4 | Feb 17, 2022 | |
| IQV IQVIA Holdings | Maintains: Overweight | n/a | $208.49 | - | 3 | Nov 17, 2021 | |
| DGX Quest Diagnostics | Maintains: Overweight | n/a | $137.09 | - | 2 | Sep 1, 2021 | |
| PHR Phreesia | Maintains: Overweight | n/a | $20.67 | - | 4 | Jul 12, 2021 | |
| RXRX Recursion Pharmaceuticals | Initiates: Overweight | n/a | $7.46 | - | 1 | May 11, 2021 | |
| AMWL American Well | Initiates: Sector Weight | n/a | $0.25 | - | 1 | Apr 16, 2021 | |
| VEEV Veeva Systems | Maintains: Overweight | n/a | $181.67 | - | 2 | Feb 17, 2021 | |
| HQY HealthEquity | Downgrades: Sector Weight | n/a | $86.62 | - | 7 | Dec 2, 2020 | |
| RCM R1 RCM | Maintains: Overweight | n/a | $12.56 | - | 1 | Jul 14, 2020 | |
| EVH Evolent Health | Downgrades: Sector Weight | n/a | $18.41 | - | 7 | Jul 6, 2020 | |
| MMS Maximus | Upgrades: Overweight | n/a | $84.89 | - | 1 | Jun 24, 2020 | |
| LH Labcorp Holdings | Maintains: Overweight | n/a | $203.13 | - | 4 | Mar 30, 2020 | |
| MDRX Veradigm | Downgrades: Sector Weight | n/a | $9.50 | - | 2 | Feb 22, 2019 | |
| ICLR ICON PLC | Maintains: Overweight | n/a | $316.51 | - | 3 | Sep 11, 2018 | |
| INCR InterCure | Maintains: Overweight | n/a | $2.03 | - | 2 | Nov 13, 2017 | |
| PINC Premier | Downgrades: Sector Weight | n/a | $18.58 | - | 1 | Oct 24, 2017 | |
| MEDP Medpace Holdings | Downgrades: Sector Weight | n/a | $407.24 | - | 1 | Jul 10, 2017 |
Teladoc Health
Feb 23, 2022
Maintains: Overweight
Price Target: $180 → $100
Current: $9.32
Upside: +972.96%
Charles River Laboratories International
Feb 17, 2022
Maintains: Overweight
Price Target: $450 → $390
Current: $203.24
Upside: +91.89%
IQVIA Holdings
Nov 17, 2021
Maintains: Overweight
Price Target: n/a
Current: $208.49
Upside: -
Quest Diagnostics
Sep 1, 2021
Maintains: Overweight
Price Target: n/a
Current: $137.09
Upside: -
Phreesia
Jul 12, 2021
Maintains: Overweight
Price Target: n/a
Current: $20.67
Upside: -
Recursion Pharmaceuticals
May 11, 2021
Initiates: Overweight
Price Target: n/a
Current: $7.46
Upside: -
American Well
Apr 16, 2021
Initiates: Sector Weight
Price Target: n/a
Current: $0.25
Upside: -
Veeva Systems
Feb 17, 2021
Maintains: Overweight
Price Target: n/a
Current: $181.67
Upside: -
HealthEquity
Dec 2, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $86.62
Upside: -
R1 RCM
Jul 14, 2020
Maintains: Overweight
Price Target: n/a
Current: $12.56
Upside: -
Evolent Health
Jul 6, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $18.41
Upside: -
Maximus
Jun 24, 2020
Upgrades: Overweight
Price Target: n/a
Current: $84.89
Upside: -
Labcorp Holdings
Mar 30, 2020
Maintains: Overweight
Price Target: n/a
Current: $203.13
Upside: -
Veradigm
Feb 22, 2019
Downgrades: Sector Weight
Price Target: n/a
Current: $9.50
Upside: -
ICON PLC
Sep 11, 2018
Maintains: Overweight
Price Target: n/a
Current: $316.51
Upside: -
InterCure
Nov 13, 2017
Maintains: Overweight
Price Target: n/a
Current: $2.03
Upside: -
Premier
Oct 24, 2017
Downgrades: Sector Weight
Price Target: n/a
Current: $18.58
Upside: -
Medpace Holdings
Jul 10, 2017
Downgrades: Sector Weight
Price Target: n/a
Current: $407.24
Upside: -